Partial Breast Irradiation in Women with Early Stage Breast Cancer

Trial ID:
IRB-20-7511
Ray Lin, M.D.
This study will test the safety and effectiveness of one week of treatment with partial breast irradiation compared to the current standard of care regimen of three weeks.
* Be 40 years of age or older.<br>* Have a diagnosis of invasive breast cancer or ductal carcinoma in-situ (DCIS).<br>* Have a breast conserving surgery in the last 12 weeks, or intend to proceed with breast conservation surgery.<br>* Be estrogen receptor positive (ER+).

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org